天臣医疗发布2025年度业绩快报，盈利0.841亿元

Core Viewpoint - Tianchen Medical is set to release its 2025 annual report, with a net profit of 84.1 million yuan, reflecting a year-on-year growth of 62.04% [1] Group 1: Operating Performance and Financial Status - During the reporting period, the company achieved an operating revenue of 326.7362 million yuan, an increase of 19.96% compared to the previous year [2] - The operating profit reached 94.2379 million yuan, showing a year-on-year growth of 71.35% [2] - The net profit attributable to the parent company was 84.0926 million yuan, up 62.04% year-on-year [2] - The net profit attributable to the parent company after deducting non-recurring gains and losses was 73.1625 million yuan, reflecting a growth of 56.53% [2] - At the end of the reporting period, total assets amounted to 672.8450 million yuan, a 5.59% increase from the beginning of the period [2] - The equity attributable to the parent company decreased by 2.92% to 564.4563 million yuan [2] - The net asset per share attributable to the parent company was 6.96 yuan, down 2.79% from the beginning of the period [2] Group 2: Factors Influencing Performance - The significant increases in operating profit, total profit, net profit attributable to the parent company, and basic earnings per share were primarily due to the company's innovation-driven strategy and the dual domestic and international market approach [3] - The stable growth in sales of endoscopic staplers contributed to the profit increase, along with improved gross margins due to economies of scale and cost optimization [3] - Currency fluctuations led to an increase in exchange gains from foreign currency monetary items held by the company [3] Group 3: Company Overview - Tianchen Medical (688013) focuses on the research, innovation, production, and sales of high-end surgical staplers [3]